logo-loader

Clinical trial for MS could prove 'immense commercial significance' of Rex Technology, says CEO

Published: 13:47 23 Jan 2017 GMT

The NHS has given clearance for a trial of the REX robot technology. The trial, aimed at MS sufferers, will be conducted in Canterbury.

CEO Crispin Simon tells Proactive: ''[The opportunity] is significant for the patients if we can improve their quality of life, enable people at the moment who have to use a wheelchair and are unable to take any form of  exercise that stretches their whole body - that's important to them''.

''If we prove it to be of any benefit to them then it's of immense commercial significance to us''.

FTSE rises ahead of Easter weekend, JD Sport gains on upbeat outlook -...

The FTSE 100 gained on the final morning of this shortened Easter trading week. Festive cheer was limited though, as Thames Water confirmed shareholders would not provide it with a £500 million rescue package, prompting speculation over the London supplier’s future. On a more positive...

1 hour, 4 minutes ago